Aflac (AFL) – Investment Analysts’ Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for Aflac (NYSE: AFL):

• 8/21/2026 – Aflac was upgraded by Weiss Ratings from “buy (b+)” to “buy (a-)”.
• 8/19/2026 – Aflac was given a new $122.00 price target by Wells Fargo & Company. They now have an “equal weight” rating on the stock.
• 8/19/2026 – Aflac is now covered by Wolfe Research. They set an “underperform” rating and a $103.00 price target on the stock.
• 8/19/2026 – Aflac is now covered by Wolfe Research. They set an “underperform” rating and a $103.00 price target on the stock.
• 8/15/2026 – Aflac was downgraded by Wall Street Zen from “hold” to “sell”.
• 8/11/2026 – Aflac had its price target lowered by JPMorgan Chase & Co. from $117.00 to $116.00. They now have a “neutral” rating on the stock.
• 8/11/2026 – Aflac had its price target raised by Keefe, Bruyette & Woods from $120.00 to $125.00. They now have a “market perform” rating on the stock.
• 8/10/2026 – Aflac had its “overweight” rating reaffirmed by Piper Sandler. They now have a $138.00 price target on the stock, up from $130.00.
• 8/10/2026 – Aflac was given a new $116.00 price target by Mizuho.
• 8/7/2026 – Aflac was downgraded by Weiss Ratings from “buy (a-)” to “buy (b+)”.
• 8/7/2026 – Aflac had its “underweight” rating reaffirmed by Barclays PLC. They now have a $99.00 price target on the stock, up from $98.00.
• 7/23/2026 – Aflac was upgraded by Weiss Ratings from “buy (b+)” to “buy (a-)”.
• 7/22/2026 – Aflac had its “hold” rating reaffirmed by TD Cowen. They now have a $110.00 price target on the stock, up from $101.00.
• 7/21/2026 – Aflac had its price target raised by JPMorgan Chase & Co. from $108.00 to $117.00. They now have a “neutral” rating on the stock.
• 7/13/2026 – Aflac had its price target raised by Keefe, Bruyette & Woods from $115.00 to $120.00. They now have a “market perform” rating on the stock.
• 7/10/2026 – Aflac had its “hold” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $108.00 price target on the stock, up from $100.00.
• 7/9/2026 – Aflac was given a new $112.00 price target by Mizuho.
• 7/9/2026 – Aflac had its price target raised by Wells Fargo & Company from $111.00 to $120.00. They now have an “equal weight” rating on the stock.
• 7/8/2026 – Aflac had its “neutral” rating reaffirmed by UBS Group AG. They now have a $124.00 price target on the stock, up from $114.00.
• 7/7/2026 – Aflac was downgraded by Weiss Ratings from “buy (a-)” to “buy (b+)”.
• 7/7/2026 – Aflac had its price target lowered by Barclays PLC from $99.00 to $98.00. They now have an “underweight” rating on the stock.

Aflac Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Wednesday, August 19th will be given a dividend of $0.61 per share. This represents a $2.44 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Wednesday, August 19th. Aflac’s dividend payout ratio is 26.15%.

Insider Transactions at Aflac

In other Aflac news, major shareholder Post Holdings Co. Ltd. Japan sold 13,000 shares of the firm’s stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $116.52, for a total transaction of $1,514,760.00. Following the completion of the sale, the insider directly owned 50,726,690 shares in the company, valued at $5,910,673,918.80. This trade represents a 0.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 522,215 shares of company stock valued at $61,386,221. Company insiders own 0.80% of the company’s stock.

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.